- Home
- DXR vs OKYO Comparison
DXR vs OKYO Comparison
Compare DXR & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- OKYO
- Stock Information
- Founded
- DXR 1970
- OKYO 2007
- Country
- DXR United States
- OKYO United Kingdom
- Employees
- DXR N/A
- OKYO N/A
- Industry
- DXR Medical/Dental Instruments
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DXR Health Care
- OKYO Health Care
- Exchange
- DXR Nasdaq
- OKYO Nasdaq
- Market Cap
- DXR 40.3M
- OKYO 37.0M
- IPO Year
- DXR N/A
- OKYO 2022
- Fundamental
- Price
- DXR $8.08
- OKYO $1.19
- Analyst Decision
- DXR Strong Buy
- OKYO Strong Buy
- Analyst Count
- DXR 1
- OKYO 1
- Target Price
- DXR $25.00
- OKYO $7.00
- AVG Volume (30 Days)
- DXR 8.9K
- OKYO 143.7K
- Earning Date
- DXR 01-01-0001
- OKYO 04-08-2025
- Dividend Yield
- DXR N/A
- OKYO N/A
- EPS Growth
- DXR 86.16
- OKYO N/A
- EPS
- DXR 0.11
- OKYO N/A
- Revenue
- DXR $119,714.00
- OKYO N/A
- Revenue This Year
- DXR N/A
- OKYO N/A
- Revenue Next Year
- DXR N/A
- OKYO N/A
- P/E Ratio
- DXR $74.70
- OKYO N/A
- Revenue Growth
- DXR N/A
- OKYO N/A
- 52 Week Low
- DXR $6.55
- OKYO $0.81
- 52 Week High
- DXR $10.00
- OKYO $1.74
- Technical
- Relative Strength Index (RSI)
- DXR 55.84
- OKYO 45.06
- Support Level
- DXR $8.02
- OKYO $1.31
- Resistance Level
- DXR $8.50
- OKYO $1.48
- Average True Range (ATR)
- DXR 0.42
- OKYO 0.11
- MACD
- DXR -0.01
- OKYO -0.03
- Stochastic Oscillator
- DXR 35.56
- OKYO 17.07
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.